These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8691989)

  • 1. Importance of the Glu 160 and Glu 189 residues to the various biological activities of the ribosome inactivating protein trichosanthin.
    Ng TB; Shaw PC; Chan WY
    Life Sci; 1996 May; 58(26):2439-46. PubMed ID: 8691989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse embryonic development and tumor cell growth under the influence of recombinant trichosanthin (a ribosome inactivating protein) and its muteins.
    Chan WY; Ng TB; Shaw PC
    Teratog Carcinog Mutagen; 1995; 15(5):259-68. PubMed ID: 8867881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position 120-123, a potential active site of trichosanthin.
    Nie H; Cai X; He X; Xu L; Ke X; Ke Y; Tam SC
    Life Sci; 1998; 62(6):491-500. PubMed ID: 9464461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity.
    Wang JH; Nie HL; Tam SC; Huang H; Zheng YT
    FEBS Lett; 2002 Nov; 531(2):295-8. PubMed ID: 12417329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the interaction of [E160A-E189A]-trichosanthin with adenine.
    Shaw PC; Wong KB; Chan DS; Williams RL
    Toxicon; 2003 Apr; 41(5):575-81. PubMed ID: 12676436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function relationship study of Gln156, Glu160 and Glu189 in the active site of trichosanthin.
    Wong KB; Ke YB; Dong YC; Li XB; Guo YW; Yeung HW; Shaw PC
    Eur J Biochem; 1994 Apr; 221(2):787-91. PubMed ID: 8174558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental toxicity and teratogenicity of trichosanthin, a ribosome-inactivating protein, in mice.
    Chan WY; Ng TB; Wu PJ; Yeung HW
    Teratog Carcinog Mutagen; 1993; 13(2):47-57. PubMed ID: 8102209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure/function relationship study of Tyr14 and Arg22 in trichosanthin, a ribosome-inactivating protein.
    Shaw PC; Mulot S; Ma SK; Xu QF; Yao HB; Wu S; Lu XH; Dong YC
    Eur J Biochem; 1997 Apr; 245(2):423-7. PubMed ID: 9151974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity.
    He XH; Shaw PC; Xu LH; Tam SC
    Life Sci; 1999; 64(14):1163-75. PubMed ID: 10210259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biological activities of trichosanthin after coupling to dextran.
    Ko WH; Yeung HW; Tam SC
    Gen Pharmacol; 1993 May; 24(3):757-62. PubMed ID: 7690000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation.
    He XH; Shaw PC; Tam SC
    Life Sci; 1999; 65(4):355-68. PubMed ID: 10421422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independency of anti-HIV-1 activity from ribosome-inactivating activity of trichosanthin.
    Wang JH; Nie HL; Huang H; Tam SC; Zheng YT
    Biochem Biophys Res Commun; 2003 Feb; 302(1):89-94. PubMed ID: 12593852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of trichosanthin at 1.88 A resolution.
    Zhou K; Fu Z; Chen M; Lin Y; Pan K
    Proteins; 1994 May; 19(1):4-13. PubMed ID: 8066085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function relationship of trichosanthin.
    Ke YB; Chen JK; Nie HL; He XH; Ke XY; Wang YH
    Life Sci; 1997; 60(7):465-72. PubMed ID: 9042374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ribosome-inactivating, antiproliferative and teratogenic activities and immunoreactivities of a protein from seeds of Luffa aegyptiaca (Cucurbitaceae).
    Ng TB; Chan WY; Yeung HW
    Gen Pharmacol; 1993 May; 24(3):655-8. PubMed ID: 8365647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis.
    An Q; Wei S; Mu S; Zhang X; Lei Y; Zhang W; Jia N; Cheng X; Fan A; Li Z; Xu Z
    J Biomed Sci; 2006 Sep; 13(5):637-43. PubMed ID: 16977428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Functional Investigation and Pharmacological Mechanism of Trichosanthin, a Type 1 Ribosome-Inactivating Protein.
    Shi WW; Wong KB; Shaw PC
    Toxins (Basel); 2018 Aug; 10(8):. PubMed ID: 30127254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.
    Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT
    Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and DNA sequence of a gene encoding alpha-trichosanthin, a type I ribosome-inactivating protein.
    Chow TP; Feldman RA; Lovett M; Piatak M
    J Biol Chem; 1990 May; 265(15):8670-4. PubMed ID: 2341400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.